Project Proposal For consideration by the Steering Committee (Please submit to the PANDRH Secretariat (PAHO): Specific Objectives

Similar documents
Regulatory Control of Diagnostics in Tanzania. Hiiti Sillo Ag. Director General Tanzania Food and Drugs Authority

White Paper. WHO assessment of vaccines regulatory system: Proposal for establishment of maturity level concept

ANVISA - Enhancing marketing authorization of drugs and medical devices in accordance to the international best practices

Global strategy and plan of action on public health, innovation and intellectual property

Regional Alignment in Asia Pacific -

Quality Assurance and Performance Improvement (QAPI)

SOUTH EASTERN TRUST. Point of Care Testing (POCT) Policy Ellie Duly, Chair POCT Committee. Approval date: Operational Date: November 2014

Concept Proposal to International Affairs Directorate

Definition of Patient-Oriented Research

MDUFA Performance Goals and Procedures Process Improvements Pre-Submissions Submission Acceptance Criteria Interactive Review

Brussels, 12 June 2014 COUNCIL OF THE EUROPEAN UNION 10855/14. Interinstitutional File: 2012/0266 (COD) 2012/0267 (COD)

ALADDIV The Latin American Alliance for the Development of the in Vitro Diagnostics

FOLLOW-UP MATRIX ON RESSCAD XXIX AGREEMENTS, ANTIGUA GUATEMALA 2013

Faster, More Efficient Innovation through Better Evidence on Real-World Safety and Effectiveness

University of Iowa Hospitals and Clinics (UIHC) DEPARTMENT OF NURSING SERVICES AND PATIENT CARE QUALITY PLAN Office of Nursing Quality

Technovigilance and risk management as tools to improve patient safety in Colombian health care institutions

Health Technology Assessment (HTA) Good Practices & Principles FIFARMA, I. Government s cost containment measures: current status & issues

Guide to Incident Reporting for General Medical Devices and Active Implantable Medical Devices

Implementing National Health Observatories

PLAN OF ACTION FOR IMPLEMENTATION OF 510(K) AND SCIENCE RECOMMENDATIONS

Administrative Policies and Procedures. Policy No.: N/A Title: Medical Equipment Management Plan

Brussels, 10 November 2003 COUNCIL THE EUROPEAN UNION 14487/03 TELECOM 144. REPORT from : COREPER date : 7 November 2003

., 1V -, QS. 44* 1, "~~~~~~~~~i,tr~;k

The Conceptual Framework for the International Classification for Patient Safety. An Overview

DG(SANCO)/ MR

Health Quality Management

II Workshop on Medicines Regulation in the Caribbean. Strengthening of National Medicines Regulation Authorities. Barbados, September 2009

Health Promotion Amendment (Amendment 173 to Annex 1)

Special session on Ebola. Agenda item 3 25 January The Executive Board,

Remediation, Resolution and Outcomes

Guide to Incident Reporting for In-vitro Diagnostic Medical Devices

Overview ICH GCP E6(R2) Integrated Addendum

Latham & Watkins Corporate Department

Point of Care Quality Management. Procedure. Approving Authority: President and CEO, Keith Dewar

Law on Medical Devices

Medical devices briefing for patients: Patient safety in the new Regulation

Andrea Garcia-Ibarra Biomedical engineer - MoHSP consultant Colombia

Online Courses in Medical Technology Application, Support and Management Improve Cost- Effectiveness and Patient Safety

A : Core Competencies for the RD 1. Scientific and Evidence Base of Practice: integration of scientific information and research into practice

Name: Anticipated Start Date: Phone: ACEND Learning Objectives & Competencies Table

International Medical Device Regulatory Harmonization. Reality or Fantasy?

Quality Improvement and Patient Safety (QPS) Ratchada Prakongsai Senior Manager

April 17, Edition of the Joint Commission International Accreditation. SUBJECT: MITA Feedback on the 5 th Standards for Hospitals

Walking the Tightrope with a Safety Net Blood Transfusion Process FMEA

International mobilization: public health emergencies of international importance. Regulators` Role

Privacy Rule Overview

European IVD Regulations and Risk Based Classification. An Overview for Global Quality Professionals

Post Market Surveillance Requirements. SAMED Regulatory Conference 2 December 2015

School of Public Health and Health Services Department of Prevention and Community Health

LATIN AMERICAN TELECOM REGULATORS FORUM

Life Extension of Nuclear Power Plants

High Level Pharmaceutical Forum

EU-CELAC Joint Initiative on Research and Innovation (JIRI) VI Senior Official Meeting (SOM) on Science and Technology. Brussels, 14 th March 2017

Council of the European Union Brussels, 24 February 2015 (OR. en)

FDA s Office of Regulatory Affairs: Violation Trends & Medical Device Update

AMERICAN BOARD OF HISTOCOMPATIBILITY AND IMMUNOGENETICS Laboratory Director. Content Outline

Take a Course of Action.

WHITE PAPER. Maximizing Pay-for-Performance Opportunities Proven Steps to Making P4P a Proactive, Successful and Sustainable Part of Your Practice

TANZANIA FOREST FUND. Call of Project Proposals. Introduction:

1. The Working Party on Public Health discussed and agreed the draft Council conclusions as set out in the Annex.

Canadian Hospital Experiences Survey Frequently Asked Questions

Changes in the Medical Device Legislation; the day after. Jan Bart Hak 1

Public health, innovation and intellectual property: global strategy and plan of action

MASTER PLAN OUTCOMES EVALUATION BSN PROGRAM

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility

DRAFT OPINION. EN United in diversity EN. European Parliament 2018/0018(COD) of the Committee on Industry, Research and Energy

GAO MEDICAL DEVICES. Status of FDA s Program for Inspections by Accredited Organizations. Report to Congressional Committees

VISION 2020 PRIORITY ACTION PROGRESS REPORT

Digital government toolkit

A Systems Approach to Patient Safety at the VA

The CLSI Consensus Process: Making a Difference in Health Care David Sterry, MT(ASCP) Director, Standards Development, CLSI

ECRI Patient Safety Organization HFACS and Healthcare

PRIMARY CARE PROVIDERS

Social and Behavioral Sciences (SBS)

LEGISLATION UPDATE & STATUS OF MCC / SAHPRA and GUIDANCE TO MEET REGULATOR S EXPECTATIONS

Special Rules of Accreditation for Certification Bodies of Quality Systems

Targeted technology and data management solutions for observational studies

NCD Surveillance: Methodology and Instruments in the Americas lecture 3

Self-Assessment Questionnaire: Establishing a Health Information Technology Safety Program

12.01 Safety Management Plan UWHC Administrative Policies

European Quality Assurance Scheme for Breast Cancer Services

2014 QAPI Plan for [Facility Name]

Postmarketing Drug Safety and Inspection Readiness

INFOSAN I N T H E REGIONAL STRATEGY TO STRENGTHEN AMERICAS INTERNATIONAL FOOD SAFETY AUTHORITIES NETWORK

Experts for experts: ENSTTI Training and Tutoring for TSOs and NRAs. Didier LOUVAT Managing Director.

Collaborative Communities: It Really Does Take a Village

Cognitive Level Certified Professional in Patient Safety Detailed Content Outline Recall. Total. Application Analysis 1.

Course Module Objectives

49th DIRECTING COUNCIL 61st SESSION OF THE REGIONAL COMMITTEE

Progress Report on Decision 7 Sustainable Consumption and Production (SCP)

DG(SANCO)/ MR

UPDATE: Regulatory Framework for Medical Devices in South Africa. SAMED Annual Conference. 14 June 2018 Jerry Molokwane

USOAP Continuous Monitoring Approach (CMA) Workshop

STEER YOUR MAGNET JOURNEY LET PROPHECY ASSESSMENTS BE YOUR GPS

28th PAN AMERICAN SANITARY CONFERENCE 64th SESSION OF THE REGIONAL COMMITTEE

MSc REGULATORY AFFAIRS MEDICINES / MEDICAL DEVICES PROSPECTUS

An Action Plan for Workforce Health and Prevention

Universal Safety Oversight Audit Programme Continuous Monitoring Manual

De Montfort University. Course Template

ALLIED PHYSICIAN IPA ADVANTAGE HEALTH NETWORK IPA ARROYO VISTA MEDICAL IPA GREATER ORANGE MEDICAL GROUP IPA GREATER SAN GABRIEL VALLEY PHYSICIANS IPA

Transcription:

Project Proposal For consideration by the Steering Committee (Please submit to the PANDRH Secretariat (PAHO): parf@paho.org) Proposed title for the area/project Proponent Strengthening of regulatory capacity on medical devices in the Region of the Americas Center for State Control of Medicines and Medical Equipment and Devices (CECMED, Cuba), together with the National Institute for Drug and Food Surveillance (INVIMA, Colombia), with the support of the Medicines and Health Technologies Unit of the Pan American Health Organization (PAHO), the Regional Advisor on Health Technologies, and the Regional Working Group on Medical Device Regulation. General Objective Identify and strengthen regulatory capacity on medical devices in the Region by training professionals who work in the regulatory authorities and by mapping the regulatory situation in the Region in order to gradually expand the work, learning, and prospects of the Regional Working Group on Medical Devices to benefit in the 35 countries of the region. Specific Objectives Objective and rationale (with reference to one or more of the objectives of the PANDRH Strategic Development Plan) Review, update, and adjust the basic indicators with regional mapping of medical device regulation in the 35 countries of the Region (Regional Working Group + remaining countries) Strengthen regional regulatory capacity on medical devices through two courses: 1) Basic course on regulation of medical devices (CECMED); and 2) Course on technological surveillance (INVIMA). Rationale: This project seeks, in a coordinated and strategic manner, to comply with Resolution WHA 67.20 on Regulatory system strengthening for medical products, in addition to focusing on WHO s prioritization of medical devices, which emphasizes regulatory oversight throughout the life cycle of medical devices something that is asymmetrical in the 35 countries of our Region. As a result, it is important to update the basic indicators and the results obtained through their application in the regional mapping led by Uruguay in 2012 in twelve NRAs of the Americas, providing information on the 35 countries in the Region. In addition, this initiative focuses on strengthening the capacity and technical assistance that the regulatory authorities of the Region of the Americas need in order to increase their regulatory capacity. It is important to give special attention to fulfilling the agreements made in the meeting of the PANDRH Directing Council in which the need to implement the decisions of the VII Conference was expressed, the work 1

being carried out on medical devices at the regional level was presented, and the importance of the results of the work done to strengthen regulatory capacity on this type of health technologies was expressed by the Members of the Steering Committee. This initiative underlines the importance that the NRAs of the Region attribute to medical device regulation and the strengthening of regulatory capacity. In light of the above, it is necessary to include these issues in PANDRH s discussions, in addition to the regional production of indicators to support the evaluation of capacity with regard to medical devices, so that the Region can make an important contribution to global discussions. 1 At the same time, taking into consideration the objectives of the Strategic Development Plan, this project falls within strategic objective IV, to promote the exchange of experiences and regulatory knowledge between NRAs within the Network and with NRAs outside PANDRH and is also justified by the need to strengthen the NRAs in order to improve access to quality health technologies and to strengthen health systems overall. 2 The existence of the PAHO/WHO Collaborating Center for the Regulation of Health Technologies in CECMED Cuba is one of the Region s strengths in terms of regulatory development for medical devices. The sharing of experiences among regulatory authorities of the Region of the Americas has become an increasingly important window for the exchange of information, knowledge, and experiences, helping to strengthen the regulatory capacity of NRAs in the Region. This initiative, coordinated by the two NRAs (INVIMA, Colombia; and CECMED, Cuba), the PAHO Regional Advisor on Health Technologies, and the Regional Working Group on Medical Device Regulation, will facilitate the generation and exchange of knowledge based on the challenges facing the Region with regard to medical devices. This is why the two authorities will bring together the best of their experience in medical device regulation in order to share it with the Region, based on the experience developed within the framework of the Regional Working Group on Medical Device Regulation and its secretariat, which provides advisory services. In Colombia, between 2010 and 2016, INVIMA has provided in-person training on post-marketing surveillance of medical devices to health professionals in the country s hospitals and clinics, health ministries, and importers and manufacturers, raising awareness among 7,560 professionals. A virtual education strategy was also implemented, and the INVIMA Learning platform was developed, based on e-learning and b- learning methodologies, with 426 people trained since 2014. 1 Minutes of the Meeting of the PANDRH Steering Committee, Washington, D.C., 27-28 May 2015 2 Strategic Development Plan 2014-2020 of the Pan American Network for Drug Regulatory Harmonization (PANDRH), p. 25 2

CECMED s Medical Devices Office has almost 20 professionals working in the areas of conformity assessment and post-marketing surveillance, with sufficient competencies to deliver the content of the proposed course. This course is accredited by the National School of Public Health, as approved by government resolution. Between 2014 and 2016, in-person and virtual training has been provided to more than 100 specialists in Cuba, including those working for manufacturers, suppliers, and distributors of medical devices, as well as health institutions. Points for consideration: In May 2016 in Brasilia, during NRAs of referenece meeting, CECMED and INVIMA presented the proposed PANDRH regional project, focused on helping to strengthen the regulatory capacity of the countries of the Region, contributing all their expertise in medical device regulation. Accordingly, INVIMA and CECMED would promote the following, with the countries of the Region and with the support of the Regional Advisor on Health Technologies / Regional Working Group on Medical Device Regulation: Scope (including points that should be addressed and opportunities for regulatory convergence) 1) Mapping of medical device regulation in the countries of the Region: a. Updating of basic indicators b. Application of the indicators in the 35 countries of the Region 2) Courses: a. Basic course on regulation of medical devices CECMED b. Technology surveillance INVIMA CECMED, through its Medical Devices Office, offers the countries of the Region its function as PAHO/WHO Collaborating Center for medical device regulation, based on international experience, regional performance, and implementation in the Cuban system. INVIMA, through the Office of Medical Devices and Other Technologies, has structured a risk management model for health surveillance in recent years. It now wishes to share the National Technology Surveillance Program and the e-learning and b-learning system with the countries of the Region. Specific Objective 1. Review, update, and adjust the basic Indicators with regional mapping of medical device regulation in the 35 Member States of PAHO (Regional Working Group + remaining countries) Activity 1.1 Conduct mapping of medical device regulation in the Region 3

The measurement instrument will be implemented in the 35 countries of the Region, using the basic indicators developed in 2012 by the Ministry of Public Health of Uruguay to determine the state of regulation of medical devices in the countries of the Working Group. The following aspects will be evaluated as part of phase I: Structure of regulation of medical devices in the country Regulation of medical devices Regulation of medical device companies/establishments Organizational structure in the area of medical devices Health risk communication Incorporation of new technologies and procurement of strategic products and supplies The PAHO Regional Advisor on Health Technologies, in collaboration with the members of the Regional Working Group on Medical Device Regulation will be in charge of coordination and communication with the countries (Annex 1: Regulation of Medical Devices in the Countries of the Region). The representatives of each country will have one month to duly complete the form and send it to PAHO. The Regional Advisor on Health Technologies / Regional Working Group on Medical Device Regulation will consolidate the information for analysis, conclusions, and preparation of the final report. Phase I: Update the current state of medical device regulation in the 16 member countries of the Working Group. Phase II: Support regional efforts to generate and consolidate information by translating documents required for English-speaking countries. Apply the instrument to generate information on medical device regulation in the remaining countries of the Region. Establish mapping of medical device regulation in the entire Region. Scope: Apply the advanced indicators in the 35 countries of the Region. Determine the regulatory gaps with respect to medical devices in the Region in order to support international cooperation. Once the regional mapping of medical device regulation in all 35 countries of the Americas has been completed, the regulatory capacity of each country will be determined. This will make it possible to better focus the actions taken by the regional group to strengthen regulatory capacity in 4

response to the needs of each country. For its part, INVIMA could support the translation and adaptation of CECMED and INVIMA training content. OBJECTIVE 2: Strengthen regional regulatory capacity on devices through two courses: Basic course on regulation of medical devices (CECMED); and Technology surveillance (INVIMA) (PRAIS community of practice) Activity 2.1 Support health education in the Region with Support of ICT Structure of virtual training courses A. Technology surveillance (INVIMA): Scope of Virtual Phase I: 100 people from the 35 countries of the Region each semester for 12 weeks. Study topics: Two (2) modules: Technology Surveillance Module: Competencies of INVIMA and general information on medical devices; components and operation of the Technology Surveillance Program in Colombia; forms of implementation and other topics of interest such as the reuse of medical devices. Foreia Module: Consists of three (3) thematic units aimed at presenting tools for the analysis and interpretation of adverse events and incidents associated with the use of medical devices, with interactive examples of applied cases using each reactive methodology studied. Scope of Phase II (Week of in-person study): Internship in Colombia for regulatory authorities who have completed the virtual phase and who are among the top 10 students. INVIMA will cover the costs through national projects with stakeholders. Topics of Study: Progress in the evaluation of efficacy and effectiveness of medical devices in Colombia Evaluation of effectiveness and licensing of medical devices Inspection, surveillance, and control of medical devices and in-vitro diagnostic reagents Post-marketing surveillance of Reagents of in-vitro diagnostic reagents Management of reported serious adverse events and incidents with medical devices Monitoring of safety alerts, recalls, and reports 5

Technical assistance and training: INVIMA VIRTUAL CLASSROOM learning modules Web application of the National Technology Surveillance Program. Signaling methodology. B. Structure of Course on Medical Device Regulation (CECMED): Scope of Virtual Phase 1: 100 people from the 35 countries of the Region each semester for 3 months. Study topics: Three (3) modules: Foundations of a regulatory program: The history of medical device regulation will be presented, from its emergence through the stages of regional development. The differences between the regulation of medical devices and medicines will be explained, while also specifying fundamental concepts in the implementation of regulatory programs. The principles, characteristics, and legal basis of regulatory programs for medical devices will be discussed. Conformity assessment of medical devices: This module will address the characteristics and principles involved in the conformity assessment of medical devices. The Cuban experience will be described, as well as recent changes in this process, taking into account recently approved WHO guidelines on the competencies of reviewers of premarket processes for medical devices. Post-marketing surveillance of medical devices: This module will present the fundamental aspects on adverse event reports by users of the Cuban health system and manufacturers of medical devices, as well as the elements of patient safety that affect optimum postmarket surveillance. 6

Objective 1: Estimated implementation period: Eight (8) months Phase I: Four (4) months Update the current state of medical device regulation in the 16 member countries of the Working Group. Phase II: Four (4) months Apply the instrument to generate information on medical device regulation in the remaining countries of the Region. Establish mapping of medical device regulation in the entire Region Scope: 35 countries of the Region. Indicators: General work plan and proposed time frames Number of participating regulatory authorities / Number of regulatory authorities in the Region Objective 2: Estimated implementation period: Six (6) months per cohort Scope: Two cohorts per year, each with 100 spaces available to the 35 countries of the Region. Tutors: 10 per cohort. Indicators: % retention: Number of registered professionals / Number of certified professionals. People trained: Total number of people trained / Total number of people scheduled for training in the period The translation of documents required for implementation of activities in 2016 will be supported by INVIMA. 7

Proposed project leader Center for State Control of Medicines and Medical Equipment and Devices (CECMED, Cuba), together with the National Institute for Drug and Food Surveillance (INVIMA, Colombia), with the support of the Medicines and Health Technologies Unit of the Pan American Health Organization (PAHO), the Regional Advisor on Health Technologies, and the Regional Working Group on Medical Device Regulation Specific objective 1: Review, update, and adjust the basic indicators with regional mapping of medical device regulation in the 35 countries of the Region (Regional Working Group + remaining countries) In 2017 it is hoped that, as part of the specific agreement with PAHO (within the framework of the technical cooperation agreement to be signed by INVIMA and PAHO in 2016), the necessary resources will be included to finance the regional mapping activities. The translation of documents required for implementation of activities in 2016 will be supported by INVIMA. Proposed sources of expertise/ financing Specific objective 2: Strengthen regional regulatory capacity on devices through two (2) courses: Basic course on regulation of medical devices (CECMED); and Technology surveillance (INVIMA) The Technology Surveillance Group of the Medical Devices Office has seven professionals with experience and training in post-marketing surveillance of medical devices, public health, patient safety, quality health systems, preventive and reactive methodologies for the analysis of adverse events, 3 management of biomedical equipment, health technology assessment, and virtual training as tutors. This initiative will have the support of seven (7) professionals who will devote four (4) hours per day to tutoring. The platform was developed by INVIMA and CECMED and will be used by the 35 countries of the Region, with 100 spaces available for professionals to register each semester. For the in-person phase, INVIMA will cover the costs through national projects with stakeholders. Relevant documents at national and international level Final Report: IV Meeting of Regulatory Authorities for the Strengthening of Regulatory Capacity on Medical Devices in the Region of the Americas. PAHO. 27-29 October 2015. Resolution WHA 67.20 on Regulatory System Strengthening for Medical Products. WHO. 2014. Clinical risk management: systematic review of the literature. Operational manual on proactive technology surveillance 3 Methodologies: Failure Modes and Effects Analysis (FMEA), London Protocol, Root Cause Analysis, Five Whys, Shell, and Human Factors Analysis and Classification System (HFACS). 8

Results of pilot proactive surveillance in five hospitals in Colombia 2012 AMFES database: https://www.invima.gov.co/avance-de-lavigilancia-proactiva-en-colombia/192-tecnovigilancia/informaciongeneral/3768-banco-de-amfes.html Martínez Pereira DM, Ríos Hernández M, Ballenilla Rodríguez TM, Álvarez Rodríguez Y, Suárez Rodríguez E, Santos Alonso JM, et al. Programa Regulador de Equipos Médicos. Experiencias en Cuba. Havana: SIMAR; 2003. Centro de Control Estatal de Equipos Médicos. Reglamento para la Evaluación y el Control Estatal de Equipos Médicos. Martínez Pereira DM, Delgado Ribas S, Suárez Rodríguez EA, (coord.) Havana: Elfos Scientiae; 2009. Regulating Conformity Assessment of Medical Devices, approved January 2016. Training manual on surveillance of medical equipment. 9